Telomeres Test + Consult

555,00

LifeLength Telomeres Test (Benelux only). Life Length is a company (2010) that provides a Telomere Analysis Technology (TAT) developed by Dr. Maria Blasco, current Director of the Spanish National Cancer Research Centre (CNIO). While some companies offer mean telomere length analyses, Life Length is the only company in the world able to offer a highly scalable technology to measure percentage of short telomeres in individual cells, which is the relevant indicator of telomere dysfunction and cellular aging. Clinical analysis provided by Life Length helps laboratories, medical companies and public institutions to determine and compare the degree of aging of individuals, cells, and selected human populations and to adopt new valuable biomarkers in several fields such as aging and age-related diseases, infertility or oncology.

The Telomeres Test for the Benelux is offered through a partner of LifeLength in The Netherlands (Baarn), Pregenius.

SKU: LIFELENGTHBELUX Category:

Description

LifeLength Telomeres Test. Life Length is a company (2010) that provides a Telomere Analysis Technology (TAT) developed by Dr. Maria Blasco, current Director of the Spanish National Cancer Research Centre (CNIO). While some companies offer mean telomere length analyses, Life Length is the only company in the world able to offer a highly scalable technology to measure percentage of short telomeres in individual cells, which is the relevant indicator of telomere dysfunction and cellular aging. Clinical analysis provided by Life Length helps laboratories, medical companies and public institutions to determine and compare the degree of aging of individuals, cells, and selected human populations and to adopt new valuable biomarkers in several fields such as aging and age-related diseases, infertility or oncology.

The Telomeres Test for the Benelux is offered through a partner of LifeLength in The Netherlands (Baarn), Pregenius.

Reviews

There are no reviews yet.

Be the first to review “Telomeres Test + Consult”